{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:15:00Z","timestamp":1790082900763,"version":"4.0.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006419","name":"EuroQol Research Foundation","doi-asserted-by":"publisher","award":["1785-RA"],"award-info":[{"award-number":["1785-RA"]}],"id":[{"id":"10.13039\/501100006419","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jval.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:11:16Z","timestamp":1761930676000},"page":"429-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Psychometric Performance of Skin, Self-Confidence, and Social Health-Related EQ-5D-5L Bolt-Ons in Patients With Atopic Dermatitis and Psoriasis in Germany"],"prefix":"10.1016","volume":"29","author":[{"given":"Ines","family":"Buchholz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Spitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thiem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"L\u00fcbke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"W\u00fclfing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Emmert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanni","family":"Rencz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib1","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/jdv.12090","article-title":"Measurement of health-related quality of life in dermatological research and practice: outcome of the EADV Taskforce on Quality of Life","volume":"27","author":"Prinsen","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib3","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-4632.2012.05798.x","article-title":"The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument","volume":"53","author":"Lebwohl","year":"2014","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","article-title":"Psychometric properties of the EQ-5D-5L: a systematic review of the literature","volume":"30","author":"Feng","year":"2021","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib5","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s40273-018-0642-5","article-title":"A systematic review of studies comparing the measurement properties of the three-level and five-level versions of the EQ-5D","volume":"36","author":"Buchholz","year":"2018","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jval.2014.09.004","article-title":"An exploratory study to test the impact on three \u201cbolt-on\u201c items to the EQ-5D","volume":"18","author":"Yang","year":"2015","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2025.10.008_bib7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/09546634.2020.1800571","article-title":"Health state utility values derived from EQ-5D in psoriatic patients: a systematic review and meta-analysis","volume":"33","author":"Yang","year":"2022","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.jval.2025.10.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jval.2014.08.1907","article-title":"An evaluation of the performance of Eq-5d: a review of reviews of psychometric properties","volume":"17","author":"Longworth","year":"2014","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib9","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1007\/s11136-022-03138-7","article-title":"Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons","volume":"31","author":"Mulhern","year":"2022","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib10","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jval.2020.12.011","article-title":"Methods used to identify, test, and assess impact on preferences of bolt-ons: a systematic review","volume":"24","author":"Geraerds","year":"2021","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2025.10.008_bib11","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jval.2025.05.015","article-title":"Development and use of cognition bolt-ons for the EQ-5D-3L and EQ-5D-5L: a systematic review","volume":"28","author":"Rencz","year":"2025","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2025.10.008_bib12","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jval.2013.10.003","article-title":"Development of a disease-specific version of the EQ-5D-5L for use in patients suffering from psoriasis: lessons learned from a feasibility study in the UK","volume":"16","author":"Swinburn","year":"2013","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/13696998.2016.1219359","article-title":"EQ-5D health utilities: exploring ways to improve upon responsiveness in psoriasis","volume":"20","author":"Pickard","year":"2017","journal-title":"J Med Econ"},{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib14","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s11136-022-03141-y","article-title":"A qualitative investigation of the relevance of skin irritation and self-confidence bolt-ons and their conceptual overlap with the EQ-5D in patients with psoriasis","volume":"31","author":"Rencz","year":"2022","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.jval.2025.10.008_bib15","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10198-025-01772-9","article-title":"Psychometric benefits of adding bolt-ons to the EQ-5D-5L in populations undergoing minimally invasive cosmetic procedures","volume":"26","author":"Muller","year":"2025","journal-title":"Eur J Health Econ"},{"issue":"4","key":"10.1016\/j.jval.2025.10.008_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s11136-024-03875-x","article-title":"Exploring the content validity of the EQ-5D-5L and four bolt-ons (skin irritation, self-confidence, sleep, social relationships) in atopic dermatitis and chronic urticaria","volume":"34","author":"Sussex","year":"2025","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11136-023-03519-6","article-title":"Content validity of the EQ-5D-5L with skin irritation and self-confidence bolt-ons in patients with atopic dermatitis: a qualitative think-aloud study","volume":"33","author":"Szl\u00e1vicz","year":"2024","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2025.10.008_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s11136-024-03871-1","article-title":"Qualitative evidence on EQ-5D-5L skin irritation and self-confidence bolt-ons in Darier\u2019s disease and Hailey-Hailey disease","volume":"34","author":"Plazar","year":"2025","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib19","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jval.2025.02.010","article-title":"Performance of the EQ-5D-5L with skin irritation and self-confidence bolt-on items in patients with urticaria","volume":"28","author":"Feng","year":"2025","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.jval.2025.10.008_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/ebj3020023","article-title":"Assessing health-related quality of life of adult patients with intermediate burns: the added value of an itching and cognition item for the EQ-5D: a retrospective observational study","volume":"3","author":"Dijkshoorn","year":"2022","journal-title":"Eur Burn J"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12955-020-01394-0","article-title":"Exploring the relation between the EQ-5D-5L pain\/discomfort and pain and itching in a sample of burn patients","volume":"18","author":"Spronk","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12325-023-02704-w","article-title":"The burden patients with myasthenia gravis experience in terms of breathing, fatigue, sleep, mental health, discomfort and usual activities in comparison to the general population","volume":"41","author":"Dewilde","year":"2024","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.jval.2025.10.008_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40271-023-00668-1","article-title":"Impact of difelikefalin on the health-related quality of life of haemodialysis patients with moderate-to-severe chronic kidney disease-associated pruritus: a single-arm intervention trial","volume":"17","author":"Fotheringham","year":"2024","journal-title":"Patient"},{"issue":"7","key":"10.1016\/j.jval.2025.10.008_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jval.2024.03.2195","article-title":"Testing the psychometric properties of 9 bolt-ons for the EQ-5D-5L in a general population sample","volume":"27","author":"Rencz","year":"2024","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13690-022-00990-4","article-title":"Anxiety, depression, and social connectedness among the general population of eight countries during the COVID-19 pandemic","volume":"80","author":"Long","year":"2022","journal-title":"Arch Public Health"},{"issue":"10023","key":"10.1016\/j.jval.2025.10.008_bib26","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"issue":"9997","key":"10.1016\/j.jval.2025.10.008_bib27","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jval.2025.10.008_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"12","key":"10.1016\/j.jval.2025.10.008_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0244765","article-title":"Psychosocial impact of skin diseases: a population-based study","volume":"15","author":"Yew","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib30","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10198-022-01460-y","article-title":"Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis","volume":"24","author":"Koszoru","year":"2023","journal-title":"Eur J Health Econ"},{"issue":"12","key":"10.1016\/j.jval.2025.10.008_bib31","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1007\/s11136-017-1699-x","article-title":"Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients","volume":"26","author":"Poor","year":"2017","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.jval.2025.10.008_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00105-019-04501-5","article-title":"[German version of the Skin Shame Scale (SSS-24): validation with dermatological patients and dermatologically healthy individuals] [article in German]","volume":"71","author":"Hiebler-Ragger","year":"2020","journal-title":"Hautarzt"},{"issue":"1-2","key":"10.1016\/j.jval.2025.10.008_bib33","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.psychres.2014.07.062","article-title":"Do patients with different mental disorders show specific aspects of shame?","volume":"220","author":"Scheel","year":"2014","journal-title":"Psychiatry Res"},{"issue":"8","key":"10.1016\/j.jval.2025.10.008_bib34","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1177\/1073191118820130","article-title":"Assessment of different dimensions of shame proneness: validation of the SHAME","volume":"27","author":"Scheel","year":"2020","journal-title":"Assessment"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib35","first-page":"244","article-title":"[Screening for mental comorbidities in dermatology: successful implementation of a screening for mental comorbidities in the field of inpatient dermatological treatment] [article in German]","volume":"72","author":"Koster","year":"2021","journal-title":"Hautarzt"},{"key":"10.1016\/j.jval.2025.10.008_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12888-016-0875-9","article-title":"The German version of the Perceived Stress Scale - psychometric characteristics in a representative German community sample","volume":"16","author":"Klein","year":"2016","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib37","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jval.2025.10.008_bib38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective","volume":"140","author":"Charman","year":"2004","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib39","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib40","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2012.147","article-title":"Dermatology life quality index (DLQI): a paradigm shift to patient-centered outcomes","volume":"132","author":"Finlay","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib41","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/jdv.20321","article-title":"The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality-of-life instruments: a systematic review","volume":"39","author":"Vyas","year":"2025","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09546634.2017.1364694","article-title":"Validation of psychometric properties and development of response criteria for the psoriasis symptoms and signs diary (PSSD): results from a phase 3 clinical trial","volume":"30","author":"Armstrong","year":"2019","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.jval.2025.10.008_bib43","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3109\/09546634.2015.1114567","article-title":"Measurement properties of a patient-reported outcome measure assessing psoriasis severity: the psoriasis symptoms and signs diary","volume":"27","author":"Mathias","year":"2016","journal-title":"J Dermatol Treat"},{"issue":"6","key":"10.1016\/j.jval.2025.10.008_bib44","first-page":"613","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ-4","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics"},{"issue":"1-2","key":"10.1016\/j.jval.2025.10.008_bib45","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jad.2009.06.019","article-title":"A 4-item measure of depression and anxiety: validation and standardization of the Patient Health Questionnaire-4 (PHQ-4) in the general population","volume":"122","author":"L\u00f6we","year":"2010","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib46","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1041610217001387","article-title":"Psychometric properties of the Perceived Stress Scale in a sample of German dementia patients and their caregivers","volume":"30","author":"Deeken","year":"2018","journal-title":"Int Psychogeriatr"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10198-024-01719-6","article-title":"The added value of the cognition, dining, gastrointestinal problems, sleep and tiredness bolt-on dimensions to the EQ-5D-5L in patients with coeliac disease","volume":"26","author":"Angyal","year":"2025","journal-title":"Eur J Health Econ"},{"issue":"5","key":"10.1016\/j.jval.2025.10.008_bib48","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jval.2025.01.006","article-title":"Development and testing of the psychometric properties of 20 bolt-on items for the EQ-5D-5L across 31 rare diseases","volume":"28","author":"Xu","year":"2025","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2025.10.008_bib49","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1016\/j.jval.2025.10.008_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11136-021-02922-1","article-title":"Combining EQ-5D-5L items into a level summary score: demonstrating feasibility using non-parametric item response theory using an international dataset","volume":"31","author":"Feng","year":"2022","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.jval.2025.10.008_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jval.2025.10.008_bib52","series-title":"5-level Bolt-Ons Have an Improved Psychometric Performance Compared to 3-level Bolt-ons in a Large, Multinational","author":"Dewilde","year":"2024"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1026410721664","article-title":"\u2018Equivalence\u2019 and the translation and adaptation of health-related quality of life questionnaires","volume":"6","author":"Herdman","year":"1997","journal-title":"Qual Life Res"},{"issue":"24","key":"10.1016\/j.jval.2025.10.008_bib54","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1097\/00007632-200012150-00014","article-title":"Guidelines for the process of cross-cultural adaptation of self-report measures","volume":"25","author":"Beaton","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.jval.2025.10.008_bib55","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1477-7525-3-37","article-title":"Order effects: a randomised study of three major cancer-specific quality of life instruments","volume":"3","author":"Cheung","year":"2005","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"10.1016\/j.jval.2025.10.008_bib56","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00005650-200307000-00002","article-title":"From the generic to the condition-specific?: instrument order effects in Quality of Life Assessment","volume":"41","author":"McColl","year":"2003","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.jval.2025.10.008_bib57","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-3530","article-title":"Patient-Oriented eczema measure score: a useful tool for web-based surveys in patients with atopic dermatitis","volume":"100","author":"Kido-Nakahara","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jval.2025.10.008_bib58","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1185\/03007990902774765","article-title":"Optimal recall periods for patient-reported outcomes: challenges and potential solutions","volume":"25","author":"Stull","year":"2009","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.jval.2025.10.008_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032859","article-title":"Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany","volume":"9","author":"Topp","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.jval.2025.10.008_bib60","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40271-022-00611-w","article-title":"Systematic review of the effect of a one-day versus seven-day recall duration on patient reported outcome measures (PROMs)","volume":"16","author":"Peasgood","year":"2023","journal-title":"Patient"},{"issue":"11","key":"10.1016\/j.jval.2025.10.008_bib61","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.jval.2021.05.006","article-title":"Performance of the EQ-5D-5L plus respiratory Bolt-On in the Birmingham chronic obstructive pulmonary disease cohort study","volume":"24","author":"Hoogendoorn","year":"2021","journal-title":"Value Health"},{"issue":"11","key":"10.1016\/j.jval.2025.10.008_bib62","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jval.2024.06.018","article-title":"Valuation of multidimensional health states with a Bolt-On: is there a shortcut?","volume":"27","author":"Yang","year":"2024","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.jval.2025.10.008_bib63","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40273-018-0629-2","article-title":"Ixekizumab for treating moderate-to-severe plaque psoriasis: an evidence review group perspective of a NICE single technology appraisal","volume":"36","author":"Ramaekers","year":"2018","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525056591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:58:06Z","timestamp":1778086686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525056591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1098301525056591"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.10.008","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychometric Performance of Skin, Self-Confidence, and Social Health-Related EQ-5D-5L Bolt-Ons in Patients With Atopic Dermatitis and Psoriasis in Germany","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}